SERA vs USB · rev $77.0K vs P/E 12, rev $28.66B
Sera Prognostics Inc (SERA) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported SERA revenue for 2024-12-31 was $77.0K. Net income was -$32.9M. Revenue was down 74.8% from 2023-12-31 to 2024-12-31. SERA currently screens at market cap $89.1M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
SERA currently screens at market cap $89.1M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the SERA and USB stock pages for the full models.
Not investment advice.